Anteris Technologies Global Corp. Share Price
AVRAnteris Technologies Global Corp. Stock Performance
Open $4.86 | Prev. Close $4.88 | Circuit Range N/A |
Day Range $4.71 - $4.92 | Year Range $2.35 - $8.79 | Volume 3,921 |
Average Traded $4.80 |
Anteris Technologies Global Corp. Share Price Chart
About Anteris Technologies Global Corp.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Anteris Technologies Global Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
02-Jan-26 | $4.86 | $4.91 | -1.51% |
31-Dec-25 | $5.08 | $4.98 | -2.26% |
30-Dec-25 | $5.40 | $5.09 | -2.67% |
29-Dec-25 | $5.64 | $5.24 | -6.52% |
26-Dec-25 | $5.46 | $5.60 | +2.94% |
24-Dec-25 | $5.26 | $5.44 | +2.93% |
23-Dec-25 | $5.30 | $5.29 | -0.38% |